» Articles » PMID: 38254676

Boosting Fitness Costs Associated with Antibiotic Resistance in the Gut: On the Way to Biorestoration of Susceptible Populations

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Jan 23
PMID 38254676
Authors
Affiliations
Soon will be listed here.
Abstract

The acquisition and expression of antibiotic resistance implies changes in bacterial cell physiology, imposing fitness costs. Many human opportunistic pathogenic bacteria, such as those causing urinary tract or bloodstream infections, colonize the gut. In this opinionated review, we will examine the various types of stress that these bacteria might suffer during their intestinal stay. These stresses, and their compensatory responses, probably have a fitness cost, which might be additive to the cost of expressing antibiotic resistance. Such an effect could result in a disadvantage relative to antibiotic susceptible populations that might replace the resistant ones. The opinion proposed in this paper is that the effect of these combinations of fitness costs should be tested in antibiotic resistant bacteria with susceptible ones as controls. This testing might provide opportunities to increase the bacterial gut stress boosting physiological biomolecules or using dietary interventions. This approach to reduce the burden of antibiotic-resistant populations certainly must be answered empirically. In the end, the battle against antibiotic resistance should be won by antibiotic-susceptible organisms. Let us help them prevail.

Citing Articles

Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for infection control.

Rios Colombo N, Ross R, Hill C Gut Microbes. 2025; 17(1):2451081.

PMID: 39817466 PMC: 11740676. DOI: 10.1080/19490976.2025.2451081.


The healthy human gut can take it all: vancomycin-variable, linezolid-resistant strains and specific bacteriocin-species interplay in spp.

Almeida-Santos A, Duarte B, Tedim A, Teixeira M, Prata J, Azevedo R Appl Environ Microbiol. 2024; 91(1):e0169924.

PMID: 39699199 PMC: 11784074. DOI: 10.1128/aem.01699-24.

References
1.
Le V, Olivera C, Spagnuolo J, Davies I, Rakonjac J . In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria. BMC Microbiol. 2020; 20(1):5. PMC: 6945529. DOI: 10.1186/s12866-019-1668-3. View

2.
Andersson D, Hughes D . Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol. 2010; 8(4):260-71. DOI: 10.1038/nrmicro2319. View

3.
San Millan A, MacLean R . Fitness Costs of Plasmids: a Limit to Plasmid Transmission. Microbiol Spectr. 2017; 5(5). PMC: 11687550. DOI: 10.1128/microbiolspec.MTBP-0016-2017. View

4.
Sistrunk J, Nickerson K, Chanin R, Rasko D, Faherty C . Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection. Clin Microbiol Rev. 2016; 29(4):819-36. PMC: 5010752. DOI: 10.1128/CMR.00031-16. View

5.
Lopez C, Delmonti J, Bonomo R, Vila A . Deciphering the evolution of metallo-β-lactamases: A journey from the test tube to the bacterial periplasm. J Biol Chem. 2022; 298(3):101665. PMC: 8889264. DOI: 10.1016/j.jbc.2022.101665. View